PLANO, Texas, May 25, 2017 /PRNewswire/ -- Artemetrx, a provider of advanced analytics and specialty drug cost-managementsolutions, was named as one of the 20 Most Promising Data Analytics Solutions Providers by CIOReview for 2017. Annually, CIOReview recognizes companies at the forefront of providing data analytics solutions and impacting the marketplace.
Artemetrx is an integrated platform that transforms data into intelligence, driving improved management of drug spend and trend across both the pharmacy and medical benefits. Built on more than 20 years of drug management expertise, the web-based platform provides users with reports, dashboards and tools that take the guesswork out of uncovering drug therapy misuse and overspending. In 2016, Artemetrx identified close to $800 million in savings opportunities for its clients.
Solutions offered on the Artemetrx platform include:
"The Artemetrx platform brings an unparalleled value proposition to the market by creating true transparency into specialty spend and trend across benefits and delivering actionable insights," said Michael Lonergan, RPh, Artemetrx President. "These capabilities put plan sponsors in a better position to manage their specialty drug spend while improving quality of care."
The CIOReview of the 20 Most Promising Data Analytics Solutions Providers for 2017 is available online at www.data-analytics.cioreview.com/vendors/2017/.
Artemetrx is the leading platform providing an integrated view of drug spending across the pharmacy and medical benefits and is a subsidiary of Pharmaceutical Strategies Group (PSG), based in Plano, Texas. PSG, a pharmacy intelligence and technology company, provides cutting-edge drug cost-management solutions. Drawing on 20+ years of best practices experience, PSG utilizes proprietary technology, data-enabled services and the industry's most trusted advisors to unlock exceptional economic value for our clients, which include Fortune 500 employers, health plans, health systems and multi-employer groups. Through benefits management, intelligent data management and innovative technology, PSG saves its clients billions of dollars each year. For more information, please visit www.artemetrx.com.
Contact: Breanna Reeves, 1-972-244-8377, [email protected]
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/artemetrx-recognized-as-one-of-the-most-promising-data-analytics-solutions-providers-300463925.html
Subscribe to our Free Newsletters!
Hyperacusis is a chronic hearing disorder characterized by an abnormal sensitivity to s ...
Proton beam therapy is a type of external radiation treatment or radiotherapy that uses protons ...
Statins are a group of drugs which help to lower the blood cholesterol levels.View All